cognitive cybersecurity intelligence

News and Analysis


With M&A Deal, Click Therapeutics’ Digital Prospects in Metabolic Disease Get Better

Digital therapeutics firm Click Therapeutics will acquire the assets of Better Therapeutics, including a mobile app for Type 2 diabetes patients called AspyreRx, following approval by the FDA. The acquisition comes after Better announced the layoff of all its employees due to lack of capital reserves. Click aims to develop a digital therapeutic for obesity using the acquired assets in combination with metabolic disorder medications.

Source: –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts